MAPK8 and sensorineural hearing loss disorder: For example, AM-111, a c-Jun N-terminal kinase (JNK) inhibitor, was found to significantly improve hearing outcomes in patients with profound idiopathic sudden SNHL [82]; it is expected to be useful in radiation-induced SNHL, which also involves the JNK signaling pathway in its pathogenesis [83].